
|Articles|April 1, 2004
Immunosuppressive drugs may pose threat in transplant patients
Washington - Dermatologists should be aware that a number of the treatments they prescribe are associated with an increased risk of skin cancer, said Mark Lebwohl, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
3
Raising the Bar for HS Outcomes With Barry Resnik, MD
4
Tofacitinib Shows Promise in Omalizumab-Resistant CSU, New Case Series Finds
5










